Dashboard
Manage Tickers

BNTCBenitec Biopharma Inc.

Nasdaq benitec.com


$ 8.62 $ 0.47 (5.77 %)    

Wednesday, 08-May-2024 15:58:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 439.55 $ 1.32 (0.3 %)
DIA $ 390.50 $ 1.77 (0.46 %)
SPY $ 517.10 $ -0.04 (-0.01 %)
TLT $ 90.18 $ -0.54 (-0.6 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 8.64
$ 8.45
$ 0.00 x 0
$ 0.00 x 0
$ 8.45 - $ 8.62
$ 1.86 - $ 10.29
11,355
na
21M
$ 1.10
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-Q
2 11-13-2023 09-30-2023 10-Q
3 09-21-2023 06-30-2023 10-K
4 05-15-2023 03-31-2023 10-Q
5 02-13-2023 12-31-2022 10-Q
6 11-10-2022 09-30-2022 10-Q
7 09-02-2022 06-30-2022 10-K
8 05-16-2022 03-31-2022 10-Q
9 02-14-2022 12-31-2021 10-Q
10 11-15-2021 09-30-2021 10-Q
11 09-20-2021 06-30-2021 10-K
12 05-12-2021 03-31-2021 10-Q
13 02-09-2021 12-31-2020 10-Q
14 11-13-2020 09-30-2020 10-Q
15 09-23-2020 06-30-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benitec-biopharma-13g-filing-shows-steven-oliveira-reported-a-889-passive-stake-in-the-co-as-of-april-22
Benitec Biopharma 13G Filing Shows Steven ...
04/29/2024 15:48:49

- SEC Filing

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-16
JMP Securities Maintains Market Outperform...
04/22/2024 16:17:56

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 20:31:32

why-is-gene-therapy-developer-benitec-biopharma-stock-trading-higher-on-thursday
Why Is Gene Therapy Developer Benitec Biop...
04/18/2024 17:04:45

Latest clinical data on BB-301 treatment for OPMD. Positive results in swallowing improvement. Benitec Biopharma announces inte...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

benitec-biopharma-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-29
Benitec Biopharma Shares Halted On Circuit...
04/18/2024 13:39:57

Core News & Articles
Market-Moving News for April 18th
04/18/2024 12:35:31

BPTH: 98% | Bio-Path Holdings shares are trading higher after the company announced the completion of its second dose cohort in...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 12:09:32

benitec-biopharma-reports-interim-clinical-trial-data-for-first-opmd-subject-treated-with-bb-301-in-phase-1b2a-study-says-bb-301-facilitated-improvements-across-multiple-measures-of-swallowing-function-in-the-first-phase-1b2a-clinical-study-subject-as-compared-to-pretreatment-assessments-conducted-during-the-observational-natural-history-portion-of-the-study
Benitec Biopharma Reports Interim Clinical...
04/18/2024 11:32:18

benitec-biopharma-reports-oversubscribed-private-placement-financing-of-40m
Benitec Biopharma Reports Oversubscribed P...
04/18/2024 11:12:29

Benitec Biopharma announced a $40.0 million private investment in public equity (PIPE) financing from the sale of 5.749 million...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/04/2024 17:34:40

benitec-biopharma-files-for-mixed-shelf-of-up-to-125m
Benitec Biopharma Files For Mixed Shelf Of...
02/23/2024 21:14:56

-SEC Filing

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-10
JMP Securities Maintains Market Outperform...
02/15/2024 18:58:07

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

benitec-biopharma-q2-eps-264-up-from-334-yoy
Benitec Biopharma Q2 EPS $(2.64) Up From $...
02/13/2024 13:06:12

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.64) per share. This is a 20.96 percent increase over losses of...

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-8
JMP Securities Maintains Market Outperform...
01/24/2024 17:14:51

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

benitec-biopharma-has-dosed-the-first-subject-in-the-bb-301-gene-therapy-phase-1b2a-trial-for-oculopharyngeal-muscular-dystrophy-related-dysphagia
Benitec Biopharma Has Dosed The First Subj...
11/30/2023 12:02:22

benitec-biopharma-q1-eps-276-up-from-799-yoy
Benitec Biopharma Q1 EPS $(2.76) Up From $...
11/13/2023 13:23:51

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(2.76) per share. This is a 65.46 percent increase over losses of...

jmp-securities-maintains-market-outperform-on-benitec-biopharma-raises-price-target-to-6
JMP Securities Maintains Market Outperform...
09/26/2023 13:01:02

JMP Securities analyst Silvan Tuerkcan maintains Benitec Biopharma (NASDAQ:BNTC) with a Market Outperform and raises the pri...

benitec-biopharma-releases-full-year-2023-financial-results-and-provides-operational-update-fy23-eps-1412-vs-3788-yoy-revenue-75k-vs-73k-yoy
Benitec Biopharma Releases Full Year 2023 ...
09/21/2023 12:19:03

why-promis-neurosciences-shares-are-trading-higher-by-33-here-are-20-stocks-moving-premarket
Why ProMIS Neurosciences Shares Are Tradin...
08/22/2023 12:31:03

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. T...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION